EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Invus is an evergreen equity investor with over $10 billion under management, empowering leaders to transform their industries. They provide the freedom to take risks, capital to reach the prize, and advice to navigate uncharted waters.
Triana Biomedicines Raises $120M in Series B Financing
Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration
Corxel Draws $287M Round to Drive Global Development of Oral GLP-1
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
Triana Biomedicines Secures $120M Series B Funding Led by Ascenta Capital and Bessemer
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners